Table of Contents Table of Contents
Previous Page  17 / 154 Next Page
Show Menu
Previous Page 17 / 154 Next Page
Page Background

Speaker’s Biographies

Regarding elderly patients with lymphoma, I have studied the role of patients frailty in association with other prognostic

factor and therapy in defining patients’ outcome.

Currently I collaborate in the conduct of the Elderly Project study, that is a prospective registry of elderly patients with

lymphoma and I am Principal Investigator of phase II study investigating the clinical activity of chemotherapy regimen

with Obinutuzumab and miniCHOP for the treatment of elderly and UNFIT patients with DLBCL.

I am author and coauthor of 82 scientific papers published on the most relevant peer-reviewed journals of oncohematology.

My H-index is 24.

Other activities:

I am president of the GRADE onlus foundation (Gruppo Amici Dell’Ematologia), non profit association with the aim to

support activities and staff of the Department of Hematology Arcispedale Santa Maria Nuova - IRCCS of Reggio Emilia,

funding research projects and assistance for patients with haematological cancers diseases.

Speaker Abstract(s): S39

Stefania Migliuolo

Europa Donna, Milan, Italy

Classically trained as MD with a Board certificate in Pediatrics. Clinical practice as pediatric oncologist followed by ten

years pharma industry experience in health marketing. Since 15 years, she moved into Healthcare communication.

She is volunteering in Europa Donna Italia, an independent non-profit organisation. Europa Donna objectives are to raise

awareness in breast cancer prevention and treatment, helping women to cope with this condition across 46 countries

and to represent the interests of European women regarding breast cancer to local and national authorities as well as to

institutions of the European Union.

Speaker Abstract(s): S40

Olivier Mir

The speaker biography has not been received at the time of publication.

Speaker Abstract(s): S41

Nicolas Mottet

Urology department, 42025, St Etienne, France

Professor Nicolas Mottet, MD, PhD is Head of the Urology Department, University Hospital, and Professor of Surgery,

University Jean Monnet, Saint-Etienne, France. He is board certified in surgery, urology and medical oncology. He is

chairman of the EAU Working Group on Prostate Cancer Guidelines, board member of the Urology Group for the French

Anti-Cancer Centre Federation, and member of the SIOG prostate and bladder cancer guidelines. He is the former

coordinator the Testis and Penile Cancer Subgroup (French Urological Association 2000–2008). He has published over

160 peer-reviewed papers and made numerous presentations and lectures; he is member of the Editorial Board of the

European Urology Journal and a reviewer of more than a dozen of high profile journals including the New England

Journal of Medicine. He sits on the scientific advisory board of several multinational pharmaceutical companies. He

coordinated or participated to more than 40 clinical trials and received several national grants. He is member of the


Loïc Mourey

Institut Claudius Regaud, Institut Universitaire du Cancer de Toulouse-Oncopole, Medical Oncology, Toulouse, France

Dr Loïc Mourey is Medical Oncologist in the comprehensive cancer center of Toulouse, in south west of France. His main

topics are genito-urinary cancers and geriatric oncology. In France, he is an active member of groups involved in geriatric

Oncology: GERICO, intergroup DIALOG, SoFOG. At the regional level, he is the co-coordinator of the Midi-Pyrénées

UCOG (Unité de Coordination en Onco-Gériatrie).

Speaker Abstract(s): S42

Arash Naeim

David Geffen School of Medicine, Department of Medicine, Los Angeles, CA, USA

Dr. Naeim is a Professor of Medicine in both Divisions of Hematology-Oncology and Geriatric Medicine at the UCLA

David Geffen School of Medicine. He is an Assistant Vice Chancellor of Research, Associate Director for the Clinical

Translational Science Institute, and Chief Medical Officer for Clinical Research for the UCLA Campus and Health

System. His research interests included outcomes research, cost-effectiveness analysis, modeling of health and frailty,

and clinical trial design in older cancer patients. His focus of research for the majority of his publications and research

grants has been in breast cancer and cancer in the elderly. He is the UCLA Principal Investigator for the Athena Breast

Health Network and NIH grant that aims to use sensor technology and analytics to reduce risk, integrate innovative

technology, and advance precision medicine in older individuals needing rehabilitation.